학술논문

Primary results from TAIL: a global single-arm safety study of atezolizumab monotherapy in a diverse population of patients with previously treated advanced non-small cell lung cancer
Document Type
Journal
Source
JOURNAL FOR IMMUNOTHERAPY OF CANCER; 2021, 9 3, pe001865 10p.
Subject
Language
English
ISSN
20511426